Qkine secures £1.5M series A funding from leading life science investors to accelerate global scale-up
Qkine – based at Cambridge Science Park is a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications – today announced the successful closure of a £1.5M series A investment round to accelerate the global...L&G secures 35,000 sq ft letting at Cambridge Science Park during lockdown
LGIM Real Assets has secured a 35,000 sq ft letting to biotechnology company Amgen at Cambridge Science Park. Amgen, which is relocating from another base at the science park, agreed to take three floors on a 10-year lease. “This letting, agreed during the...SoCode Recruitment launch into Finance, HR, Sales & Marketing sectors!
SoCode are pleased to announce the launch of our Professional Services Division to support clients in Cambridge with Permanent and Contract requirements within the following sectors: Finance & AccountingHR & Talent Acquisition Business...Oxford Gene Technology (OGT), has developed a breakthrough targeted NGS panel for constitutional cytogenetics research.
The new CytoSure™ NGS panel—launching early in 2020—will combine the strengths of microarrays and NGS to deliver a comprehensive all-in-one assay. The new panel, in conjunction with OGT’s popular Interpret analysis software facilitates the accurate and confident...
